Search - tctmd.com

Displaying 1 - 20 of 92

Sort: Relevancy | Date

Presentation ESC 2024

INFINITY-SWEDEHEART: Percutaneous coronary intervention with a Bioadaptor compared to a contemporary Drug-eluting Stent (DES) in a large broad clinical population

Presenter: David Erlinge

September 02, 2024

Presentation EuroPCR 2023

BIOADAPTOR RCT: Randomized Controlled Trial of Sirolimus-Eluting Bioadaptor Scaffold Versus Zotarolimus-Eluting Drug-Eluting Stent

Presenter: Shigeru Saito

May 18, 2023

Presentation TCT 2020

The HOST-Reduce-Polytech-ACS trial: Durable Polymer versus Biodegradable Polymer Drug-Eluting Stents after percutaneous coronary intervention in patients with Acute Coronary Syndrome

Presenter: Hyo-Soo Kim

October 17, 2020

Presentation TCT Abstracts Posters 2018

Tackling bifurcation PCI in complicated STEMI: switching from single to two-stent strategy as bail-out

Presenter: Fathima Aaysha Cader

September 25, 2018

Presentation TCT Abstracts Posters 2018

Randomized comparison of an everolimus-eluting bioresorbable scaffold versus everolimus-eluting metallic stent in primary percutaneous coronary intervention of ST-segment elevation myocardial infarction

Presenter: Omeed Neghabat

September 25, 2018

Presentation ESC 2018

ISAR-Absorb MI: A Prospective, Randomized Trial of BVS vs EES in Patients Undergoing Coronary Stenting for Myocardial Infarction

Presenter: Robert Byrne

August 29, 2018

Presentation

Mid- and Long-term Outcome Comparisons of Absorb BVS vs Everolimus-Eluting Stent

October 17, 2017

Presentation iASSESS 2017

STEMI: Treatment Strategies, Drugs And Devices

Presenter: Dharam J. Kumbhani

August 24, 2017

Presentation

Incidence, Predictors, and Clinical Outcomes of Early Stent Thrombosis After Primary PCI

July 28, 2017

Presentation EuroPCR 2017

Randomized Comparison of Everolimus-eluting Bioresorbable Vascular Scaffolds vs. Everolimus-eluting Metallic Stents in Patients with Coronary Artery Disease: 3-year Clinical Outcomes from ABSORB China

Presenter: Runlin Gao

May 17, 2017

Presentation

Economic Outcomes of Absorb BVSvs Everolimus-Eluting Stents in PCI

April 18, 2017

Presentation

Beyond Restenosis: Patients’ Preference for Drug-Eluting or Bare-Metal Stents

February 13, 2017

Presentation

10-Year Clinical Outcome After Randomization to Sirolimus- or Paclitaxel-Eluting Coronary stents

February 13, 2017

Presentation JIM 2017

The COMBO Plus Dual Therapy Stent: Clinical Update and Experience

Presenter: Gennaro Sardella

February 09, 2017

Presentation Cardiovascular Interventions 2016

Unprotected Left Main Stenting

Presenter: Paul S. Teirstein

November 10, 2016

Presentation ESC 2016

Effective Anti-thrombotic Therapy without Stenting: Intravascular OCT-based Management in Plaque Erosion (the EROSION study)

Presenter: Ik-Kyung Jang

August 30, 2016

Presentation

Prolonged High-Dose Bivalirudin Infusion Reduces Major Bleeding Without Increasing Stent Thrombosis in Patients Undergoing Primary PCI

Presenter: Gregor Fahrni

July 27, 2016

Presentation

Dedicated Bifurcation Stent for the Treatment of Bifurcation Lesions Involving Large Side Branches

Presenter: Philippe Généreux

July 07, 2016

Presentation

Effect of Post-PPCI Bivalirudin Infusion on Acute Stent Thrombosis: Meta-analysis of RCTs

Presenter: Rahman Shah

June 20, 2016

Presentation EuroPCR 2016

Biolimus-A9 polymer-free coated stent in high bleeding risk patients with acute coronary syndrome: a LEADERS FREE ACS substudy

Presenter: Christoph Naber

May 19, 2016

Advertisement

INFINITY-SWEDEHEART: Percutaneous coronary intervention with a Bioadaptor compared to a contemporary Drug-eluting Stent (DES) in a large broad clinical population

BIOADAPTOR RCT: Randomized Controlled Trial of Sirolimus-Eluting Bioadaptor Scaffold Versus Zotarolimus-Eluting Drug-Eluting Stent

The HOST-Reduce-Polytech-ACS trial: Durable Polymer versus Biodegradable Polymer Drug-Eluting Stents after percutaneous coronary intervention in patients with Acute Coronary Syndrome

Tackling bifurcation PCI in complicated STEMI: switching from single to two-stent strategy as bail-out

Randomized comparison of an everolimus-eluting bioresorbable scaffold versus everolimus-eluting metallic stent in primary percutaneous coronary intervention of ST-segment elevation myocardial infarction

ISAR-Absorb MI: A Prospective, Randomized Trial of BVS vs EES in Patients Undergoing Coronary Stenting for Myocardial Infarction

Mid- and Long-term Outcome Comparisons of Absorb BVS vs Everolimus-Eluting Stent

STEMI: Treatment Strategies, Drugs And Devices

Incidence, Predictors, and Clinical Outcomes of Early Stent Thrombosis After Primary PCI

Randomized Comparison of Everolimus-eluting Bioresorbable Vascular Scaffolds vs. Everolimus-eluting Metallic Stents in Patients with Coronary Artery Disease: 3-year Clinical Outcomes from ABSORB China

Economic Outcomes of Absorb BVSvs Everolimus-Eluting Stents in PCI

Beyond Restenosis: Patients’ Preference for Drug-Eluting or Bare-Metal Stents

10-Year Clinical Outcome After Randomization to Sirolimus- or Paclitaxel-Eluting Coronary stents

The COMBO Plus Dual Therapy Stent: Clinical Update and Experience

Unprotected Left Main Stenting

Effective Anti-thrombotic Therapy without Stenting: Intravascular OCT-based Management in Plaque Erosion (the EROSION study)

Prolonged High-Dose Bivalirudin Infusion Reduces Major Bleeding Without Increasing Stent Thrombosis in Patients Undergoing Primary PCI

Dedicated Bifurcation Stent for the Treatment of Bifurcation Lesions Involving Large Side Branches

Effect of Post-PPCI Bivalirudin Infusion on Acute Stent Thrombosis: Meta-analysis of RCTs

Biolimus-A9 polymer-free coated stent in high bleeding risk patients with acute coronary syndrome: a LEADERS FREE ACS substudy

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content